Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3740060016 | Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3740061017 | Ethambutol and isoniazid and pyrazinamide and rifampin only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3740062012 | Product containing only ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4574001000052114 | läkemedel som endast innehåller etambutol, isoniazid, pyrazinamid och rifampicin, oral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form | Has active ingredient | Isoniazid (substance) | true | Inferred relationship | Some | 4 | |
Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form | Has active ingredient | Pyrazinamide (substance) | true | Inferred relationship | Some | 1 | |
Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form | Is a | Ethambutol and isoniazid and pyrazinamide and rifampicin only product | true | Inferred relationship | Some | ||
Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form | Is a | Product containing ethambutol and isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form | Has active ingredient | Ethambutol (substance) | true | Inferred relationship | Some | 2 | |
Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form | räkning av bas i aktiv ingrediens | fyra | false | Inferred relationship | Some | ||
Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form | Has active ingredient | Rifampicin | true | Inferred relationship | Some | 3 | |
Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form | Plays role | Antitubercular therapeutic role | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets